2022. Transcriptomic and Proteomic Profiling of Circulating Tumor Cells to Identify Predictive Biomarkers of Chemotherapeutic Response in Triple-Negative Breast Cancer. ICMERD-International Journal of Medical Science (ICMERD-IJMS). 3, 1 (Jan. 2022), 1–7.